Virtual Medicinal Product (VMP) - Noradrenaline (base) 2mg/2ml solution for infusion ampoules
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Noradrenaline (base) 2mg/2ml solution for infusion ampoules | Start Date 20-08-2010 | End Date |
| Previous Name | Previous Name Noradrenaline 4mg/2ml solution for infusion ampoules | Start Date 20-01-2009 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- C01CA03
- BNF Codes
-
- BNF code 02070200
| Code | Start Date | End Date |
|---|---|---|
| 36032511000001101 | 29-10-2018 | |
| 319558007 | 01-07-2004 | 28-10-2018 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Noradrenaline acid tartrate | Based on Base Substance | Noradrenaline | 1 mg | 1 ml |
Name
Noradrenaline acid tartrate
Basis of strength description
Based on Base Substance
BOSS
Noradrenaline
Strength and UOM (Nmr)
1.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMNoradrenaline
-
VMP(Current) Noradrenaline (base) 2mg/2ml solutio...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 5 ampoule | ||
| 6 ampoule | ||
| 10 ampoule |